{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:23:12Z","timestamp":1781212992745,"version":"3.54.1"},"reference-count":115,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Federal Agency of Scientific Organizations of Russia","award":["075-0152-22-00"],"award-info":[{"award-number":["075-0152-22-00"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Being initially described as a factor of virally-induced leukemias, Fli1 (Friend leukemia integration 1) has attracted considerable interest lately due to its role in both healthy physiology and a variety of pathological conditions. Over the past few years, Fli1 has been found to be one of the crucial regulators of normal hematopoiesis, vasculogenesis, and immune response. However, abnormal expression of Fli1 due to genetic predisposition, epigenetic reprogramming (modifications), or environmental factors is associated with a few diseases of different etiology. Fli1 hyperexpression leads to malignant transformation of cells and progression of cancers such as Ewing\u2019s sarcoma. Deficiency in Fli1 is implicated in the development of systemic sclerosis and hypertensive disorders, which are often accompanied by pronounced fibrosis in different organs. This review summarizes the initial findings and the most recent advances in defining the role of Fli1 in diseases of different origin with emphasis on its pro-fibrotic potential.<\/jats:p>","DOI":"10.3390\/ijms24031881","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T02:51:37Z","timestamp":1674096697000},"page":"1881","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Fli1 and Tissue Fibrosis in Various Diseases"],"prefix":"10.3390","volume":"24","author":[{"given":"Elena V.","family":"Mikhailova","sequence":"first","affiliation":[{"name":"Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, 44 Thorez Avenue, 194223 Saint-Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0348-0631","authenticated-orcid":false,"given":"Irina V.","family":"Romanova","sequence":"additional","affiliation":[{"name":"Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, 44 Thorez Avenue, 194223 Saint-Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2903-8673","authenticated-orcid":false,"given":"Alexei Y.","family":"Bagrov","sequence":"additional","affiliation":[{"name":"Padakonn Pharma, 20309 Narva, Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia I.","family":"Agalakova","sequence":"additional","affiliation":[{"name":"Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, 44 Thorez Avenue, 194223 Saint-Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1073\/pnas.87.4.1332","article-title":"Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus","volume":"87","author":"Giddens","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1101\/gad.5.6.908","article-title":"Erythroleukemia induction by Friend murine leukemia virus: Insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1","volume":"5","author":"Giddens","year":"1991","journal-title":"Genes Dev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"107127","DOI":"10.1016\/j.intimp.2020.107127","article-title":"Emerging role of Fli1 in autoimmune diseases","volume":"90","author":"He","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00018-022-04160-1","article-title":"Current insights into the role of Fli-1 in hematopoiesis and malignant transformation","volume":"79","author":"Klarke","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1247\/csf.26.19","article-title":"Role of ETS family transcription factors in vascular development and angiogenesis","volume":"26","author":"Sato","year":"2001","journal-title":"Cell Struct. Funct."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/CIRCRESAHA.121.318986","article-title":"Fli1 Promotes Vascular Morphogenesis by Regulating Endothelial Potential of Multipotent Myogenic Progenitors","volume":"129","author":"Ferdous","year":"2021","journal-title":"Circ. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1128\/MCB.20.15.5643-5652.2000","article-title":"Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor","volume":"20","author":"Spyropoulos","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/2397198318758221","article-title":"What can we learn from Fli1-deficient mice, new animal models of systemic sclerosis?","volume":"3","author":"Asano","year":"2018","journal-title":"Scleroderma Relat. Disord."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1182\/blood-2005-12-4929","article-title":"Endoglin expression in the endothelium is regulated by Fli-1, Erg, and Elf-1 acting on the promoter and a \u22128-kb enhancer","volume":"107","author":"Pimanda","year":"2006","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Le Bras, A., Samson, C., Trentini, M., Caetano, B., Lelievre, E., Mattot, V., Beermann, F., and Soncin, F. (2010). VE-statin\/egfl7 expression in endothelial cells is regulated by a distal enhancer and a proximal promoter under the direct control of Erg and GATA-2. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012156"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1093\/emboj\/cdg549","article-title":"VE-statin, an endothelial repressor of smooth muscle cell migration","volume":"22","author":"Soncin","year":"2003","journal-title":"EMBO J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"25143","DOI":"10.1074\/jbc.M201628200","article-title":"Ets-1 regulates fli-1 expression in endothelial cells. Identification of ETS binding sites in the fli-1 gene promoter","volume":"277","author":"Lionneton","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ijbiomac.2022.04.076","article-title":"Transcription factor Fli-1 as a new target for antitumor drug development","volume":"209","author":"Li","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s12253-019-00765-3","article-title":"Review: Ewing Sarcoma Predisposition","volume":"26","author":"Gargallo","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.canlet.2022.01.009","article-title":"ETS factors in prostate cancer","volume":"530","author":"Qian","year":"2022","journal-title":"Cancer Lett."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"F1219","DOI":"10.1152\/ajprenal.90710.2008","article-title":"Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: Implications for uremic cardiomyopathy","volume":"296","author":"Elkareh","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Agalakova, N.I., Kolodkin, N.I., Adair, C.D., Trashkov, A.P., and Bagrov, A.Y. (2021). Preeclampsia: Cardiotonic Steroids, Fibrosis, Fli1 and Hint to Carcinogenesis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041941"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/exd.13341","article-title":"The impact of transcription factor Fli1 deficiency on the regulation of angiogenesis","volume":"26","author":"Toyama","year":"2017","journal-title":"Exp. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.biocel.2015.06.004","article-title":"Epigenetic suppression of Fli1, a potential predisposing factor in the pathogenesis of systemic sclerosis","volume":"67","author":"Asano","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1759720X20918456","DOI":"10.1177\/1759720X20918456","article-title":"The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: A comprehensive overview","volume":"12","author":"Fioretto","year":"2020","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.2147\/IJGM.S356877","article-title":"Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis","volume":"15","author":"Yu","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kowalska-K\u0119pczy\u0144ska, A.J. (2022). Systemic Scleroderma-Definition, Clinical Picture and Laboratory Diagnostics. Clin. Med., 11.","DOI":"10.3390\/jcm11092299"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"642891","DOI":"10.3389\/fimmu.2021.642891","article-title":"Elevated Fibronectin Levels in Profibrotic CD14+ Monocytes and CD14+ Macrophages in Systemic Sclerosis","volume":"12","author":"Rudnik","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.semcdb.2022.03.019","article-title":"Tenascin-C in fibrosis in multiple organs: Translational implications","volume":"128","author":"Bhattacharyya","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"20839","DOI":"10.1074\/jbc.M010133200","article-title":"Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway","volume":"276","author":"Shirasaki","year":"2001","journal-title":"Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/exd.12619","article-title":"Fli1 deficiency and beyond: A unique pathway linking peripheral vasculopathy and dermal fibrosis in systemic sclerosis","volume":"24","author":"Manetti","year":"2015","journal-title":"Exp. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1084\/jem.20160247","article-title":"Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma","volume":"214","author":"Takahashi","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Asano, Y.J. (2020). The Pathogenesis of Systemic Sclerosis: An Understanding Based on a Common Pathologic Cascade across Multiple Organs and Additional Organ-Specific Pathologies. Clin. Med., 9.","DOI":"10.3390\/jcm9092687"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0002-9440(10)63685-1","article-title":"Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin","volume":"163","author":"Kubo","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13075-021-02520-z","article-title":"Fli1 deficiency suppresses RALDH1 activity of dermal dendritic cells and related induction of regulatory T cells: A possible role in scleroderma","volume":"23","author":"Miura","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1080\/21655979.2021.1907128","article-title":"Bushen Yijing Decoction (BSYJ) exerts an anti-systemic sclerosis effect via regulating MicroRNA-26a\/FLI1 axis","volume":"12","author":"Cheng","year":"2021","journal-title":"Bioengineered"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"25259","DOI":"10.1074\/jbc.M600466200","article-title":"Fli1 and Ets1 have distinct roles in connective tissue growth factor\/CCN2 gene regulation and induction of the profibrotic gene program","volume":"281","author":"Nakerakanti","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3892\/ijmm.2012.1150","article-title":"Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1","volume":"30","author":"Bujor","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2353\/ajpath.2010.090593","article-title":"Endothelial Fli1 deficiency impairs vascular homeostasis: A role in scleroderma vasculopathy","volume":"176","author":"Asano","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/rheumatology\/keu479","article-title":"Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis","volume":"54","author":"Akamata","year":"2015","journal-title":"Rheumatology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/exd.14218","article-title":"Serum S100A12 levels: Possible association with skin sclerosis and interstitial lung disease in systemic sclerosis","volume":"30","author":"Omatsu","year":"2021","journal-title":"Exp. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/nar\/gki275","article-title":"Alpha2(I) collagen gene regulation by protein kinase C signaling in human dermal fibroblasts","volume":"33","author":"Jinnin","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"34672","DOI":"10.1074\/jbc.M703907200","article-title":"Transforming growth factor-beta regulates DNA binding activity of transcription factor Fli1 by p300\/CREB-binding protein-associated factor-dependent acetylation","volume":"282","author":"Asano","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1128\/MCB.01320-08","article-title":"Phosphorylation of Fli1 at threonine 312 by protein kinase C delta promotes its interaction with p300\u2044CREB-binding protein-associated factor and subsequent acetylation in response to transforming growth factor beta","volume":"29","author":"Asano","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/art.30284","article-title":"The c-Abl tyrosine kinase controls protein kinase C\u03b4-induced Fli-1 phosphorylation in human dermal fibroblasts","volume":"63","author":"Bujor","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1365-2133.2012.11055.x","article-title":"Constitutive activation of c-Abl\/protein kinase C-\u03b4\/Fli1 pathway in dermal fibroblasts derived from patients with localized scleroderma","volume":"167","author":"Noda","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/ar4529","article-title":"Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1","volume":"16","author":"Akamata","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Noda, S., Asano, Y., Akamata, K., Aozasa, N., Taniguchi, T., Takahashi, T., Ichimura, Y., Toyama, T., Sumida, H., and Yanaba, K. (2012). A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0032272"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/rheumatology\/kes379","article-title":"Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis","volume":"52","author":"Noda","year":"2013","journal-title":"Rheumatology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/exd.12920","article-title":"A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis","volume":"25","author":"Yamashita","year":"2016","journal-title":"Exp. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/art.39312","article-title":"Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis","volume":"67","author":"Ichimura","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jdermsci.2018.09.005","article-title":"Progranulin overproduction due to constitutively activated c-Abl\/PKC-\u03b4\/Fli1 pathway contributes to the resistance of dermal fibroblasts to the anti-fibrotic effect of tumor necrosis factor-\u03b1 in localized scleroderma","volume":"92","author":"Miyagawa","year":"2018","journal-title":"Dermatol. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00403-013-1431-9","article-title":"Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis","volume":"306","author":"Ichimura","year":"2014","journal-title":"Arch. Dermatol. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3899\/jrheum.161092","article-title":"Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis","volume":"44","author":"Taniguchi","year":"2017","journal-title":"J. Rheumatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/exd.13724","article-title":"CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis","volume":"27","author":"Taniguchi","year":"2018","journal-title":"Exp. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jdermsci.2021.07.006","article-title":"Contribution to the peripheral vasculopathy and endothelial cell dysfunction by CXCL4 in Systemic Sclerosis","volume":"104","author":"Jiang","year":"2021","journal-title":"J. Dermatol. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s13075-021-02667-9","article-title":"Endothelial CCR6 expression due to FLI1 deficiency contributes to vasculopathy associated with systemic sclerosis","volume":"23","author":"Ikawa","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/bjd.14183","article-title":"Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: A possible role in prothrombotic conditions","volume":"174","author":"Saigusa","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/rheumatology\/kez517","article-title":"Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis","volume":"59","author":"Miyagawa","year":"2020","journal-title":"Rheumatology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/ar2189","article-title":"Genetic factors in systemic sclerosis","volume":"9","author":"Mayes","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1093\/rheumatology\/keaa306","article-title":"Association of functional (GA)n microsatellite polymorphism in the FLI1 gene with susceptibility to human systemic sclerosis","volume":"59","author":"Yamashita","year":"2020","journal-title":"Rheumatology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.21948","article-title":"Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts","volume":"54","author":"Wang","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1136\/annrheumdis-2014-205303","article-title":"Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies","volume":"74","author":"Altorok","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/08916934.2019.1621856","article-title":"MicroRNA-21 and microRNA-29a modulate the expression of collagen in dermal fibroblasts of patients with systemic sclerosis","volume":"52","author":"Gharibdoost","year":"2019","journal-title":"Autoimmunity"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/art.27443","article-title":"MicroRNA-29, a key regulator of collagen expression in systemic sclerosis","volume":"62","author":"Maurer","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.4049\/jimmunol.1200822","article-title":"The downregulation of miR-let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma","volume":"190","author":"Makino","year":"2013","journal-title":"J. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1684\/ejd.2014.2384","article-title":"Downregulation of microRNA-196a in the sera and involved skin of localized scleroderma patients","volume":"24","author":"Makino","year":"2014","journal-title":"Eur. J. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"25066","DOI":"10.1038\/srep25066","article-title":"IL-13 mediates collagen deposition via STAT6 and microRNA-135b: A role for epigenetics","volume":"6","author":"Ciechomska","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1179546821998347","DOI":"10.1177\/1179546821998347","article-title":"Uraemic Cardiomyopathy: A Review of Current Literature","volume":"15","author":"Garikapati","year":"2021","journal-title":"Clin. Med. Insights Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.1128\/MCB.15.12.6961","article-title":"An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes","volume":"15","author":"Zhang","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.HYP.0000202594.82271.92","article-title":"Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy","volume":"47","author":"Kennedy","year":"2006","journal-title":"Hypertension"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/01.HYP.0000252409.36927.05","article-title":"Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy","volume":"49","author":"Elkareh","year":"2007","journal-title":"Hypertension"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/ajh.2012.17","article-title":"Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure","volume":"25","author":"Haller","year":"2012","journal-title":"Am. J. Hypertens."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5019287","DOI":"10.1155\/2019\/5019287","article-title":"Endogenous Bufadienolides, Fibrosis and Preeclampsia","volume":"2019","author":"Reznik","year":"2019","journal-title":"Cardiol. Res. Pract."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"105669","DOI":"10.1016\/j.earlhumdev.2022.105669","article-title":"Preeclampsia: Maternal cardiovascular function and optimising outcomes","volume":"174","author":"Dennehy","year":"2022","journal-title":"Early Hum. Dev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/HJH.0000000000003213","article-title":"Preeclampsia and severe acute respiratory syndrome coronavirus 2 infection: A systematic review","volume":"40","author":"Tossetta","year":"2022","journal-title":"J. Hypertens."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Opichka, M.A., Rappelt, M.W., Gutterman, D.D., Grobe, J.L., and McIntosh, J.J. (2021). Vascular Dysfunction in Preeclampsia. Cells, 10.","DOI":"10.3390\/cells10113055"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/HJH.0b013e32834436a7","article-title":"In preeclampsia endogenous cardiotonic steroids induce vascular fibrosis and impair relaxation of umbilical arteries","volume":"29","author":"Nikitina","year":"2011","journal-title":"J. Hypertens."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Fedorova, O.V., Ishkaraeva, V.V., Grigorova, Y.N., Reznik, V.A., Kolodkin, N.I., Zazerskaya, I.E., Zernetkina, V., Agalakova, N.I., Tapilskaya, N.I., and Adair, C.D. (2018). Antibody to Marinobufagenin Reverses Placenta-Induced Fibrosis of Umbilical Arteries in Preeclampsia. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19082377"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Agalakova, N.I., Grigorova, Y.N., Ershov, I.A., Reznik, V.A., Mikhailova, E.V., Nadei, O.V., Samuilovskaya, L., Romanova, L.A., Adair, C.D., and Romanova, I.V. (2022). Canrenone Restores Vasorelaxation Impaired by Marinobufagenin in Human Preeclampsia. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23063336"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/ajh\/hpz180","article-title":"Antibody against Na\/K-ATPase Inhibitor Lowers Blood Pressure and Increases Vascular Fli1 in Experimental Preeclampsia","volume":"33","author":"Agalakova","year":"2020","journal-title":"Am. J. Hypertens."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/ajh\/hpac065","article-title":"Silencing of Fli1 Gene Mimics Effects of Preeclampsia and Induces Collagen Synthesis in Human Umbilical Arteries","volume":"35","author":"Agalakova","year":"2022","journal-title":"Am. J. Hypertens."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1093\/ndt\/gfq772","article-title":"Endogenous cardiotonic steroids in chronic renal failure","volume":"26","author":"Kolmakova","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/FJC.0000000000000730","article-title":"Marinobufagenin induces vascular fibrosis via a pressure-independent mechanism in NaCl-loaded diabetic rats","volume":"74","author":"Fedorova","year":"2019","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e012138","DOI":"10.1161\/JAHA.119.012138","article-title":"Monoclonal Antibody to Marinobufagenin Downregulates TGF\u03b2 Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt-Sensitive Hypertension","volume":"8","author":"Zhang","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/ajh\/hpv155","article-title":"Monoclonal antibody to an endogenous sodium pump inhibitor marinobufagenin reverses aortic remodeling and stiffness in normotensive rats on a high salt intake","volume":"29","author":"Grigorova","year":"2016","journal-title":"Am. J. Hypertens."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-018-0003-x","article-title":"Ewing sarcoma","volume":"4","author":"Surdez","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra2028910","article-title":"Ewing\u2019s Sarcoma","volume":"384","author":"Riggi","year":"2021","journal-title":"N. Eng. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2217\/14796694.1.4.521","article-title":"Ewing\u2019s sarcoma oncoprotein EWS-FLI1: The perfect target without a therapeutic agent","volume":"1","author":"Uren","year":"2005","journal-title":"Future Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4020-5133-3_4","article-title":"EWS-FLI1 in Ewing\u2019s sarcoma: Real targets and collateral damage","volume":"587","author":"Ban","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/gcc.10153","article-title":"Induction of tenascin-C by tumor-specific EWS-ETS fusion genes","volume":"36","author":"Watanabe","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e69734","DOI":"10.7554\/eLife.69734","article-title":"Dysregulated heparan sulfate proteoglycan metabolism promotes Ewing sarcoma tumor growth","volume":"11","author":"Vasileva","year":"2022","journal-title":"eLife"},{"key":"ref_88","first-page":"3230","article-title":"DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma","volume":"14","author":"Bailly","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"ref_89","first-page":"423","article-title":"Multiple domains mediate transformation by the Ewing\u2019s sarcoma EWS\/FLI-1 fusion gene","volume":"10","author":"Lessnick","year":"1995","journal-title":"Oncogene"},{"key":"ref_90","unstructured":"Goldman, L., Cecil, R.L., and Schafer, A.I. (2012). Goldman\u2019s Cecil Medicine, Elsevier Saunders. [24th ed.]."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Johnson, K.M., Taslim, C., Saund, R.S., and Lessnick, S.L. (2017). Identification of two types of GGAA-microsatellites and their roles in EWS\/FLI binding and gene regulation in Ewing sarcoma. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186275"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"9870","DOI":"10.1073\/pnas.1701872114","article-title":"Role for the EWS domain of EWS\/FLI in binding GGAA-microsatellites required for Ewing sarcoma anchorage independent growth","volume":"114","author":"Johnson","year":"2017","journal-title":"Proc. Natl. Acad. Sci USA"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Li, M., and Chen, C.W. (2022). Epigenetic and Transcriptional Signaling in Ewing Sarcoma-Disease Etiology and Therapeutic Opportunities. Biomedicines, 10.","DOI":"10.3390\/biomedicines10061325"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/s41416-019-0608-1","article-title":"EWS-FLI1-mediated tenascin-C expression promotes tumor progression by targeting MALAT1 through integrin \u03b15\u03b21-mediated YAP activation in Ewing sarcoma","volume":"121","author":"He","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1038\/sj.onc.1203811","article-title":"Interference with the constitutive activation of ERK1 and ERK2 impairs EWS\/FLI-1-dependent transformation","volume":"19","author":"Silvany","year":"2000","journal-title":"Oncogene"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"56889","DOI":"10.18632\/oncotarget.10872","article-title":"Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK\/ERK pathway","volume":"7","year":"2016","journal-title":"Oncotarget"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Agra, N., Cidre, F., Garc\u00eda-Garc\u00eda, L., de la Parra, J., and Alonso, J. (2013). Lysyl oxidase is downregulated by the EWS\/FLI1 oncoprotein and its propeptide domain displays tumor suppressor activities in Ewing sarcoma cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066281"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e135188","DOI":"10.1172\/jci.insight.135188","article-title":"Wnt\/\u03b2-catenin-activated Ewing sarcoma cells promote the angiogenic switch","volume":"5","author":"Hawkins","year":"2020","journal-title":"JCI Insight"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ccell.2014.10.004","article-title":"EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma","volume":"26","author":"Riggi","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_100","first-page":"1199","article-title":"Epigenetic control of the EWS-FLI1 promoter in Ewing\u2019s sarcoma","volume":"43","author":"Montoya","year":"2020","journal-title":"Oncol. Rep."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1054\/bjoc.2000.1652","article-title":"Downregulation and forced expression of EWS-Fli1 fusion gene results in changes in the expression of G(1)regulatory genes","volume":"84","author":"Matsumoto","year":"2001","journal-title":"Br. J. Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1073\/pnas.0810759106","article-title":"EZH2 is a mediator of EWS\/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation","volume":"106","author":"Richter","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.4161\/15592294.2014.988048","article-title":"Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs","volume":"12","author":"Svoboda","year":"2014","journal-title":"Epigenetics"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1101\/gad.1899710","article-title":"EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells","volume":"24","author":"Riggi","year":"2010","journal-title":"Genes Dev."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/onc.2013.541","article-title":"The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma","volume":"34","author":"Parrish","year":"2015","journal-title":"Oncogene"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"De Feo, A., Pazzaglia, L., Ciuffarin, L., Mangiagli, F., Pasello, M., Simonetti, E., Pellegrini, E., Ferrari, C., Bianchi, G., and Spazzoli, B. (2022). miR-214-3p is commonly downregulated by EWS-FLI1 and by CD99 and its restoration limits Ewing sarcoma aggressiveness. Cancers, 14.","DOI":"10.3390\/cancers14071762"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"De Vito, C., Riggi, N., Suv\u00e0, M.L., Janiszewska, M., Horlbeck, J., Baumer, K., Provero, P., and Stamenkovic, I. (2011). Let-7a is a direct EWS-FLI-1 target implicated in Ewing\u2019s sarcoma development. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023592"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1048705","DOI":"10.3389\/fonc.2022.1048705","article-title":"Harnessing immunomodulation during DNA damage in Ewing sarcoma","volume":"12","author":"Daley","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1158\/0008-5472.CAN-11-3648","article-title":"PARP-1 inhibition as a targeted strategy to treat Ewing\u2019s sarcoma","volume":"72","author":"Brenner","year":"2012","journal-title":"Cancer Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"215984","DOI":"10.1016\/j.canlet.2022.215984","article-title":"Ablation of EWS-FLI1 by USP9X inhibition suppresses cancer cell growth in Ewing sarcoma","volume":"552","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nm.1983","article-title":"A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing\u2019s sarcoma","volume":"15","author":"Erkizan","year":"2009","journal-title":"Nat. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"11500","DOI":"10.1200\/JCO.2021.39.15_suppl.11500","article-title":"TK216 for relapsed\/refractory Ewing sarcoma: Interim phase 1\/2 results","volume":"39","author":"Ludwig","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12943-022-01641-6","article-title":"Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma","volume":"21","author":"Matzek","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jid.2016.08.037","article-title":"Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis","volume":"137","author":"Yamashita","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jid.2018.11.016","article-title":"Cyclophosphamide Pulse Therapy Normalizes Vascular Abnormalities in a Mouse Model of Systemic Sclerosis Vasculopathy","volume":"139","author":"Yamashita","year":"2019","journal-title":"J. Investig. Dermatol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/1881\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:09:01Z","timestamp":1760119741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/1881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":115,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24031881"],"URL":"https:\/\/doi.org\/10.3390\/ijms24031881","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,18]]}}}